NCT03494335

Brief Summary

In this exploratory study, the researchers would like to investigate the background, perception, current use practices, potential unmet needs and/or challenges in regard to imaging procedures, imaging technology, or any other aspect related to the broader field of imaging.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 11, 2018

Completed
4.4 years until next milestone

Study Start

First participant enrolled

August 30, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 18, 2024

Status Verified

January 1, 2024

Enrollment Period

2.3 years

First QC Date

March 30, 2018

Last Update Submit

January 16, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Perception of PET/CT imaging agent Y-90

    To evaluate participants' perceptions of Y-90 using a likert scale on an online survey

    through study completion, on average 2-5 years

  • Perception of PET/CT imaging agent NaF

    To evaluate participants' perceptions of NaF using a likert scale on an online survey

    through study completion, on average 2-5 years

  • Perception of MRI contrast agents

    To evaluate participants' perceptions of MR contrast agents using a likert scale

    through study completion, on average 2-5 years

Study Arms (1)

Volunteer participants

Volunteer participants will participate in surveys assessing their perception of various imaging aspects.

Other: Online surveys

Interventions

The investigators are recruiting health care providers for these surveys that are involved in or use imaging.

Volunteer participants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of volunteers agreeing to complete the survey tool. It is anticipated that the surveys will be completed by participants that can be considered stakeholders, such as physicians, technologist's physicists, imaging scientists, administrative staff, or others with interest in the topic.

You may qualify if:

  • Male and female participants who have access to the online survey tool and can read and write in English

You may not qualify if:

  • None, as this is voluntary

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Martha Morehouse Medical Plaza

Columbus, Ohio, 43221, United States

Location

Study Officials

  • Michael V Knopp, MD, PhD

    Ohio State University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 30, 2018

First Posted

April 11, 2018

Study Start

August 30, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

January 18, 2024

Record last verified: 2024-01

Locations